101 related articles for article (PubMed ID: 15284078)
1. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography.
Nishiuma T; Sisson TH; Subbotina N; Simon RH
Am J Respir Cell Mol Biol; 2004 Nov; 31(5):552-8. PubMed ID: 15284078
[TBL] [Abstract][Full Text] [Related]
2. Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs.
Wygrecka M; Markart P; Ruppert C; Petri K; Preissner KT; Seeger W; Guenther A
Eur Respir J; 2007 Jun; 29(6):1105-14. PubMed ID: 17331968
[TBL] [Abstract][Full Text] [Related]
3. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF
J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787
[TBL] [Abstract][Full Text] [Related]
5. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
[TBL] [Abstract][Full Text] [Related]
6. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; RamÃrez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.
Eitzman DT; McCoy RD; Zheng X; Fay WP; Shen T; Ginsburg D; Simon RH
J Clin Invest; 1996 Jan; 97(1):232-7. PubMed ID: 8550840
[TBL] [Abstract][Full Text] [Related]
9. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
Kotani I; Sato A; Hayakawa H; Urano T; Takada Y; Takada A
Thromb Res; 1995 Mar; 77(6):493-504. PubMed ID: 7624837
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition.
Idell S; James KK; Gillies C; Fair DS; Thrall RS
Am J Pathol; 1989 Aug; 135(2):387-99. PubMed ID: 2476934
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.
Matsuoka H; Sisson TH; Nishiuma T; Simon RH
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):705-13. PubMed ID: 16840775
[TBL] [Abstract][Full Text] [Related]
12. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
[TBL] [Abstract][Full Text] [Related]
14. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
Sisson TH; Hattori N; Xu Y; Simon RH
Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
[TBL] [Abstract][Full Text] [Related]
16. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
[TBL] [Abstract][Full Text] [Related]
18. Increased basigin in bleomycin-induced lung injury.
Betsuyaku T; Kadomatsu K; Griffin GL; Muramatsu T; Senior RM
Am J Respir Cell Mol Biol; 2003 May; 28(5):600-6. PubMed ID: 12707016
[TBL] [Abstract][Full Text] [Related]
19. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.
Madtes DK; Elston AL; Kaback LA; Clark JG
Am J Respir Cell Mol Biol; 2001 May; 24(5):599-607. PubMed ID: 11350830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
